These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1654590)

  • 1. Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):135-8. PubMed ID: 1654590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
    Jennings FW
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on lipidomimetic derivatives of alpha-difluoromethylornithine (DFMO) to enhance the bioavailability in a Trypanosoma B. brucei murine trypanosomiasis model.
    Loiseau PM; Czok M; Chauffert O; Bourass J; Letourneux Y
    Parasite; 1998 Sep; 5(3):239-46. PubMed ID: 9772723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.
    Jennings FW; Ulrich P; Cerami A
    Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental trypanosomiasis in pigs.
    Jibike GI; Anika SM
    Br Vet J; 1991; 147(6):556-64. PubMed ID: 1777799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
    Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of 5-substituted 2-nitroimidazoles (Ro 15-0216 and benznidazole) and DL-alpha-difluoromethylornithine on Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R; Sayer PD; van Nieuwenhove S
    Ann Soc Belg Med Trop; 1990 Dec; 70(4):269-79. PubMed ID: 2291692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
    Bouteille B; Darde ML; Pestre-Alexandre M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eflornithine. A new drug in the treatment of sleeping sickness.
    Van Bogaert I; Haemers A
    Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
    Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
    Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we need new drugs against human African trypanosomiasis?
    Stich A; Ponte-Sucre A; Holzgrabe U
    Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207
    [No Abstract]   [Full Text] [Related]  

  • 17. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
    Breton JC; Bouteille B; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
    Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
    Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Steverding D; Rushworth SA
    Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.